TUSTIN, Calif., Sep. 19 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL - News), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that Jade Pharmaceutical Inc. posted revenues of $3.095 million for the six months ended June 30, 2006, up 42.7 percent compared to revenues of $2.169 million for the same period in 2005. Jade Pharmaceutical posted revenues of $1.884 million for the three months ended June 30, 2006, up 56.9 percent compared to revenues of $1.201 million for the same three months in 2005.
